Infra-orbital Nerve Block for Post Operative Analgesia in Children Undergoing Cleft Lip Surgery.
NCT ID: NCT02514980
Last Updated: 2017-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
30 participants
INTERVENTIONAL
2015-08-31
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nalbuphine as Adjuvant During Bilateral Suprazygomatic Maxillary Nerve Block for Pediatric Cleft Palate Repair
NCT06100315
Nebulized Bupivacaine Analgesia for Cleft Palate Repair
NCT04928352
Dexamethasone & Ketamine as Adjuvants to Bupivacaine for Incisional Infiltration in Pediatric Abdominal Operations
NCT05190952
Suprazygomatic Block in Cleft Palate Surgery in Children
NCT03412474
Clonidine for Infra-orbital Nerve Block During Pediatric Cleft Lip Revision Surgeries
NCT05790044
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators designed this study to evaluate the safety and analgesic efficacy of adding ketamine to bupivacaine in bilateral infra-orbital nerve block for relief of pain postoperatively following repair of cleft lip in children less than two years of age.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bupivacaine group
Infraorbital nerve block using bupivacaine 0.25% on each side.
Bupivacaine
Infraorbital nerve block using bupivacaine 0.25% on each side.
Bupivacaine-Ketamine group.
Infraorbital nerve block using bupivacaine 0.25% combined with 0.5mg/kg ketamine on each side.
Bupivacaine
Infraorbital nerve block using bupivacaine 0.25% on each side.
Ketamine
Infraorbital nerve block using 0.5mg/kg ketamine on each side.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bupivacaine
Infraorbital nerve block using bupivacaine 0.25% on each side.
Ketamine
Infraorbital nerve block using 0.5mg/kg ketamine on each side.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
3 Months
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hala Saad Abdel-Ghaffar
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hala S Abdel-Ghaffar, MD
Role: PRINCIPAL_INVESTIGATOR
Assisstant professor in Anesthesia and intensive care department, faculty of medicine, Assiut university, Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut university hospitals
Asyut, Assiut Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00008718/ ref. no.103
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.